Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sepsis Diagnostics Market, by Method
1.4.2 Europe Sepsis Diagnostics Market, by Test Type
1.4.3 Europe Sepsis Diagnostics Market, by Pathogen
1.4.4 Europe Sepsis Diagnostics Market, by Product
1.4.5 Europe Sepsis Diagnostics Market, by End-User
1.4.6 Europe Sepsis Diagnostics Market, by Technology
1.4.7 Europe Sepsis Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players
Chapter 4. Europe Sepsis Diagnostics Market by Method
4.1 Europe Conventional Market by Country
4.2 Europe Automated Market by Country
Chapter 5. Europe Sepsis Diagnostics Market by Test Type
5.1 Europe Laboratory Tests Market by Country
5.2 Europe Point-of-Care Tests Market by Country
Chapter 6. Europe Sepsis Diagnostics Market by Pathogen
6.1 Europe Bacterial Sepsis Market by Country
6.2 Europe Fungal Sepsis Market by Country
6.3 Europe Viral Sepsis Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Sepsis Diagnostics Market by Product
7.1 Europe Blood Culture Media Market by Country
7.2 Europe Assays & Reagents Market by Country
7.3 Europe Instruments Market by Country
7.4 Europe Software Market by Country
Chapter 8. Europe Sepsis Diagnostics Market by End-User
8.1 Europe Hospitals & specialty clinics Market by Country
8.2 Europe Pathology & Reference Laboratories Market by Country
8.3 Europe Research Laboratories & Academic Institutes Market by Country
Chapter 9. Europe Sepsis Diagnostics Market by Technology
9.1 Europe Blood Culture Market by Country
9.2 Europe Immunoassays Market by Country
9.3 Europe Molecular Diagnostics Market by Country
9.4 Europe Flow Cytometry Market by Country
9.5 Europe Microfluidics Market by Country
9.6 Europe Biomarkers Market by Country
Chapter 10. Europe Sepsis Diagnostics Market by Country
10.1 Germany Sepsis Diagnostics Market
10.1.1 Germany Sepsis Diagnostics Market by Method
10.1.2 Germany Sepsis Diagnostics Market by Test Type
10.1.3 Germany Sepsis Diagnostics Market by Pathogen
10.1.4 Germany Sepsis Diagnostics Market by Product
10.1.5 Germany Sepsis Diagnostics Market by End-User
10.1.6 Germany Sepsis Diagnostics Market by Technology
10.2 UK Sepsis Diagnostics Market
10.2.1 UK Sepsis Diagnostics Market by Method
10.2.2 UK Sepsis Diagnostics Market by Test Type
10.2.3 UK Sepsis Diagnostics Market by Pathogen
10.2.4 UK Sepsis Diagnostics Market by Product
10.2.5 UK Sepsis Diagnostics Market by End-User
10.2.6 UK Sepsis Diagnostics Market by Technology
10.3 France Sepsis Diagnostics Market
10.3.1 France Sepsis Diagnostics Market by Method
10.3.2 France Sepsis Diagnostics Market by Test Type
10.3.3 France Sepsis Diagnostics Market by Pathogen
10.3.4 France Sepsis Diagnostics Market by Product
10.3.5 France Sepsis Diagnostics Market by End-User
10.3.6 France Sepsis Diagnostics Market by Technology
10.4 Russia Sepsis Diagnostics Market
10.4.1 Russia Sepsis Diagnostics Market by Method
10.4.2 Russia Sepsis Diagnostics Market by Test Type
10.4.3 Russia Sepsis Diagnostics Market by Pathogen
10.4.4 Russia Sepsis Diagnostics Market by Product
10.4.5 Russia Sepsis Diagnostics Market by End-User
10.4.6 Russia Sepsis Diagnostics Market by Technology
10.5 Spain Sepsis Diagnostics Market
10.5.1 Spain Sepsis Diagnostics Market by Method
10.5.2 Spain Sepsis Diagnostics Market by Test Type
10.5.3 Spain Sepsis Diagnostics Market by Pathogen
10.5.4 Spain Sepsis Diagnostics Market by Product
10.5.5 Spain Sepsis Diagnostics Market by End-User
10.5.6 Spain Sepsis Diagnostics Market by Technology
10.6 Italy Sepsis Diagnostics Market
10.6.1 Italy Sepsis Diagnostics Market by Method
10.6.2 Italy Sepsis Diagnostics Market by Test Type
10.6.3 Italy Sepsis Diagnostics Market by Pathogen
10.6.4 Italy Sepsis Diagnostics Market by Product
10.6.5 Italy Sepsis Diagnostics Market by End-User
10.6.6 Italy Sepsis Diagnostics Market by Technology
10.7 Rest of Europe Sepsis Diagnostics Market
10.7.1 Rest of Europe Sepsis Diagnostics Market by Method
10.7.2 Rest of Europe Sepsis Diagnostics Market by Test Type
10.7.3 Rest of Europe Sepsis Diagnostics Market by Pathogen
10.7.4 Rest of Europe Sepsis Diagnostics Market by Product
10.7.5 Rest of Europe Sepsis Diagnostics Market by End-User
10.7.6 Rest of Europe Sepsis Diagnostics Market by Technology
Chapter 11. Company Profiles
11.1 BioMérieux S.A.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Acquisition and Mergers:
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Approvals and Trials:
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Product Launches and Product Expansions:
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Thermo Fisher Scientific, Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Approvals and Trials:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 DiaSorin S.p.A. (Luminex Corporation)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Acquisitions and Mergers:
11.7 Bruker Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Product Launches and Product Expansions:
11.7.5.2 Acquisition and Mergers:
11.8 Siemens Healthineers AG (Siemens AG)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Partnerships, Collaborations, and Agreements:
11.8.5.2 Acquisition and Mergers:
11.9 Danaher Corporation
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.10. Quidel Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 Recent strategies and developments:
11.10.5.1 Acquisition and Mergers:
Unique Offerings 
